Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Profil Institut für Stoffwechselforschung GmbH clinical trials
The registry lists 25 studies whose lead sponsor is Profil Institut für Stoffwechselforschung GmbH. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 24, 2024.
Registry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Profil Institut für Stoffwechselforschung GmbH.
- Profil Institut für Stoffwechselforschung GmbH25 studiesSame company
Something wrong?
Focus areas
Conditions Profil Institut für Stoffwechselforschung GmbH leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 25 of 25.
- Clinical Experimental Study to Investigate Specific Features of ClampArt®CompletedNCT01906970Not applicable
- Validation of the Doubly Labelled Water Method in Subjects With Type 2 Diabetes MellitusCompletedNCT02518581Not applicable
- Explorative Assessment of Biomarkers in Overweight and Obese SubjectsCompletedNCT01910051
- Sitagliptin and the Risk for Hypoglycaemia in Type 2 Diabetes PatientsCompletedNCT03359590Phase 2
- Empagliflozin and Sympathetic Nerve TrafficCompletedNCT03254849Phase 4
- Effects of Victoza® Versus Lyxumia® on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid SecretionTerminatedNCT02231658Phase 1
- A Study to Investigate the Glucose Lowering Effects of Dextromethorphan Alone or in Combination With Sitagliptin in Subjects With Type 2 Diabetes Mellitus (T2DM) After an Oral Glucose Tolerance TestCompletedNCT01936025Phase 2
- An Exploratory Clinical Trial to Generate Whole Blood Samples for Analysing Genetic PolymorphismsWithdrawnNCT02057497
- DIATOR-Diabetes Intervention With AtorvastatinTerminatedNCT00974740Phase 1
- Effects of Linagliptin on Active GLP-1 Concentrations in Subjects With Renal ImpairmentCompletedNCT01903070Phase 4
- Effects of Linagliptin in Addition to Empagliflozin on Islet Cell PhysiologyCompletedNCT02401880Phase 4
- Impact of Combined of Lantus(Insulin Glargine) and Lyxumia (Lixisenatide) on Insulin Secretion and Gastric EmptyingCompletedNCT01910194Phase 2
- A Trial to Compare the PK and PD of Insulin Lispro Administered Into Different Tissues in Subjects With Diabetes Mellitus Type 1CompletedNCT02221323Phase 2
- A Trial Investigating the Influence of Injection Speed and Volume on the Perception of Subcutaneous Injection PainCompletedNCT01937702Phase 1
- Trial to Compare the Relative Pharmacodynamic Properties of Different Glucagon DosagesCompletedNCT01916265Phase 1
- A Trial Investigating the Accuracy and Precision of the BGStar® and iBGStar® Blood Glucose Meter in Subjects With Type 1 DiabetesCompletedNCT01730885Phase 4
- Dextromethorphan, Amantadine and Glucose Homeostasis in Diabetes SubjectsCompletedNCT01441986Phase 2
- Effects of Food Advanced Glycation Endproducts on Vascular Function in DiabetesCompletedNCT01456026Not applicable
- Performance Study Using the OptiScanner on Healthy DiabeticsCompletedNCT01135771Phase 1
- Glucose Clamp Study to Prove Hypo- and Hyperglycemic Episodes Using a Non-invasive Glucose Monitoring DeviceCompletedNCT01060917Phase 1/2
- Changes in Serum Electrolytes at Different Glucose Concentrations + Impact on a Non-invasive Glucose Monitoring MethodCompletedNCT01058577Phase 1
- Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 DiabetesCompletedNCT00982254Phase 1
- Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 DiabetesCompletedNCT00971659Phase 1
- Expanded PK and PD of Insulin Glulisine Versus Insulin Aspart in Healthy VolunteersCompletedNCT00969592Phase 1
- Metabolic Effect of Insulin Aspart and Human Insulin in Different DosesCompletedNCT00513643Phase 1